FEB 03, 2021 8:08 AM PST

New Panel of Arthritis Biomarkers Diagnoses Disease With 93.2% Accuracy

WRITTEN BY: Tara Fernandez

Rheumatoid arthritis, or RA, is a painful and debilitating autoimmune disorder of the joints, particularly those of the wrists and hands. The disease can also affect other parts of the body, causing inflammation of vital organs and anemia. As of 2015, 24.5 million people are estimated to be living with RA.

A study published in Arthritis Research & Therapy has detailed the development of a panel of four RA biomarkers, improving the accuracy and reliability of RA diagnoses, of which false negatives are an ongoing issue.

This panel of four includes measurements of angiotensinogen (AGT), serum amyloid A-4 protein (SAA4), vitamin D-binding protein (VDBP), and retinol-binding protein-4 (RBP4). These were determined through an in-depth analysis of samples from a cohort of over 250 RA patients alongside 230 healthy individuals.

Conventional diagnostic biomarkers, immunoglobin M and anti-CCP aren’t the most reliable for detecting RA, particularly at the early stages. “Existing biomarkers have limitations concerning RA diagnosis. For example, the sensitivity and specificity of RF are 60-90% and 85%, respectively,” wrote the authors. 

“To improve the efficiency of RA diagnosis, anti-CCP is used with RF. Anti-CCP has higher ACCP positivity than RF positivity among RA patients; however, the sensitivity and specificity of the 2 markers do not significantly differ.”

The newly-identified panel of four biomarkers performs significantly better, say the authors. “Together, the 4-biomarker panel accurately classified 234 healthy controls and 210 RA patients with a classification accuracy of 93.2% and 91.7% for healthy controls and RA patients, respectively.”

Though there is no cure for the disease and no known prevention other than a reduction of risk factors where possible, an early diagnosis is critical in managing the disease. The hope is that evolving clinical practices to detect and monitor RA more effectively will improve the quality of life for these patients.

 



Source: Arthritis Research & Therapy.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 26, 2021
Genetics & Genomics
Connecting Bacterial Genes to Human Disease
MAY 26, 2021
Connecting Bacterial Genes to Human Disease
This kind of research gets us closer to using fecal samples to get a snapshot of the microbiome, and make disease risk p ...
JUN 04, 2021
Clinical & Molecular DX
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
JUN 04, 2021
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
  Scientists have developed miniaturized 3-dimensional bone marrow models that could help physicians to predict whi ...
JUN 30, 2021
Clinical & Molecular DX
A Deep Learning Tool for Faster, Better Heart Disease Diagnoses
JUN 30, 2021
A Deep Learning Tool for Faster, Better Heart Disease Diagnoses
A new deep learning tool could help slash the time it takes to interpret cardiology scans to diagnose obstructive corona ...
JUL 13, 2021
Clinical & Molecular DX
Friend or Foe? New Cancer-Tracking Pen Guides Surgeons.
JUL 13, 2021
Friend or Foe? New Cancer-Tracking Pen Guides Surgeons.
Researchers have developed the first diagnostic “pen” that acts as a guide for surgeons, helping them distin ...
AUG 17, 2021
Clinical & Molecular DX
Sleep Apnea Doubles the Risk of Sudden Death
AUG 17, 2021
Sleep Apnea Doubles the Risk of Sudden Death
Obstructive sleep apnea, or OSA, is the most commonly reported sleep disorder, with loud snoring being one of the tell-t ...
SEP 16, 2021
Drug Discovery & Development
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
SEP 16, 2021
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
According to the Population Reference Bureau, 40 million people in the United States are aged 65 and older. This nu ...
Loading Comments...